UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000030402
Receipt No. R000034712
Official scientific title of the study Effect of the new surface anesthesia at the time of injection
Date of disclosure of the study information 2018/01/04
Last modified on 2017/12/14 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Effect of the new surface anesthesia at the time of injection
Title of the study (Brief title) Effect of the new surface anesthesia
Region
Japan

Condition
Condition None
Classification by specialty
Oral surgery
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To clarify the efficacy of the new surface anesthesia at
the time of injection
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The reduced level of the pain of needle at the time of
injection by the new surface anesthesia
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine Maneuver
Interventions/Control_1 Usage of the new surface anesthesia
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >
Gender Male and Female
Key inclusion criteria The patient who will receive blood draw or infusion more than twice during observation period.
Key exclusion criteria The patient who have allergy against lidocaine,
aminobenzoate or adrenalin.

The patient who have possibility of pregnancy or nursing.

Target sample size 20

Research contact person
Name of lead principal investigator Mishima Katsuaki
Organization Yamaguchi University Graduate School of Medicine
Division name Department of Oral and Maxillofacial Surgery
Address 1-1-1 Minamikogushi, Ube 755-8505, Japan
TEL 0836-22-2297
Email kmishima@yamaguchi-u.ac.jp

Public contact
Name of contact person Harada Koji
Organization Yamaguchi University Graduate School of Medicine
Division name Department of Oral and Maxillofacial Surgery
Address 1-1-1 Minamikogushi, Ube 755-8505, Japan
TEL 0836-22-2299
Homepage URL
Email harako@yamaguchi-u.ac.jp

Sponsor
Institute Yamaguchi University
Institute
Department

Funding Source
Organization Yamaguchi University
Organization
Division
Category of Funding Organization Government offices of other countries
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 01 Month 04 Day

Progress
Recruitment status Preinitiation
Date of protocol fixation
2017 Year 12 Month 11 Day
Anticipated trial start date
2018 Year 01 Month 04 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2017 Year 12 Month 14 Day
Last modified on
2017 Year 12 Month 14 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034712